Anika Therapeutics | ANIK - Vermögenswerte

Aktienkurs
14.69
Täglich Wechseln
-0.26 -1.74%
Monatlich
-0.41%
Jährlich
4.33%
Q2 Prognose
14.54




Vermögenswerte Veränderung Datum
Abbott USD 110.43B 23.72B 2026-03
Agenus USD 226.8M 7.09M 2025-12
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Anika Therapeutics USD 179.39M 10.88M 2026-03
Arrowhead Research USD 1.6B 218.89M 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 200.89B 1.68B 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Merit Medical Systems USD 2.72B 33.36M 2026-03
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 128.02B 1.22B 2026-03
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 46.29B 1.55B 2026-03
Surmodics USD 169.82M 8.74M 2025-06
Veracyte USD 1.44B 30.38M 2026-03
Xencor USD 875.5M 6.68M 2025-12
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03